Latin America Companion Diagnostics Market - By Type: Genetic Tests, Protein Biomarker Tests, Companion Drug Tests; By Application: Oncology, Neurology, Infectious Diseases, Cardiology; By End-user: Hospitals, Clinics, Research Institutes; By Country: Brazil, Mexico, Argentina, Colombia and Rest of Latin America
8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
8.2 Latin America Companion Diagnostics Market - Opportunity Analysis Index,
By Type,
By Application,
By End-user,
and Region, 2024 - 2031
9. Latin America Latin America Companion Diagnostics Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.1.1 Genetic Tests
9.1.2 Protein Biomarker Tests
9.1.3 Companion Drug Tests
9.2 By Application Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.2.1 Oncology
9.2.2 Neurology
9.2.3 Infectious Diseases
9.2.4 Cardiology
9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.3.1 Hospitals
9.3.2 Clinics
9.3.3 Research Institutes
9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
9.4.1 Brazil
9.4.2 Mexico
9.4.3 Argentina
9.4.4 Peru
9.4.5 Colombia
9.4.6 Rest of Latin America
9.5 Latin America
Latin America Companion Diagnostics Market – Opportunity Analysis Index,
By Type,
By Application,
By End-user,
and Country, 2024 - 2031
9.6 Regional Trends Analysis
9.7 Latin America Latin America Companion Diagnostics Market Research Report - Company Profiles
9.7.1 Company 1 (Brazil)
9.7.2 Company 2 (Mexico)
9.7.3 Company 3 (Mexico)
10. Competition Landscape
10.1 Strategic Dashboard of Top Market Players
10.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
10.2.1 Roche Diagnostics
10.2.2 Agilent Technologies
10.2.3 Thermo Fisher Scientific
10.2.4 Abbott Laboratories
10.2.5 Qiagen N.V.
11. Data Collection Method and Research Approach 12. Principal Presumptions and Acronyms
Methodology & Credibility
Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
